Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Nutrisystem (NTRI) Share Price

Media coverage about Nutrisystem (NASDAQ:NTRI) has trended somewhat positive on Tuesday, according to Accern. The research firm ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Nutrisystem earned a news sentiment score of 0.18 on Accern’s scale. Accern also assigned news articles about the company an impact score of 45.5377884246375 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

These are some of the news articles that may have effected Accern’s scoring:

How to Become a New Pot Stock Millionaire

NASDAQ NTRI opened at $29.50 on Tuesday. Nutrisystem has a 1 year low of $26.06 and a 1 year high of $67.95. The company has a market capitalization of $850.36, a price-to-earnings ratio of 15.05, a PEG ratio of 0.83 and a beta of 1.12.

Nutrisystem (NASDAQ:NTRI) last posted its earnings results on Monday, February 26th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.40 by $0.02. Nutrisystem had a net margin of 8.30% and a return on equity of 48.69%. The business had revenue of $131.20 million for the quarter, compared to analysts’ expectations of $128.75 million. During the same period in the prior year, the company posted $0.29 EPS. The business’s revenue for the quarter was up 20.5% compared to the same quarter last year. equities analysts anticipate that Nutrisystem will post 2.05 earnings per share for the current fiscal year.

A number of analysts recently commented on NTRI shares. BidaskClub cut shares of Nutrisystem from a “sell” rating to a “strong sell” rating in a research note on Thursday, April 19th. ValuEngine cut shares of Nutrisystem from a “hold” rating to a “sell” rating in a research note on Monday, April 2nd. Argus cut shares of Nutrisystem from a “buy” rating to a “hold” rating in a research note on Tuesday, March 20th. Citigroup dropped their price target on shares of Nutrisystem from $67.00 to $39.00 and set a “buy” rating on the stock in a research note on Monday, March 5th. Finally, B. Riley set a $52.00 price target on shares of Nutrisystem and gave the company a “buy” rating in a research note on Wednesday, February 28th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the stock. Nutrisystem currently has an average rating of “Hold” and a consensus price target of $57.00.

In other Nutrisystem news, insider Dawn M. Zier sold 30,825 shares of the stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $40.37, for a total value of $1,244,405.25. Following the sale, the insider now directly owns 221,013 shares in the company, valued at approximately $8,922,294.81. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.04% of the company’s stock.

TRADEMARK VIOLATION WARNING: This story was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another domain, it was illegally stolen and republished in violation of US and international copyright and trademark legislation. The original version of this story can be read at

About Nutrisystem

Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.

Insider Buying and Selling by Quarter for Nutrisystem (NASDAQ:NTRI)

Receive News & Ratings for Nutrisystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrisystem and related companies with's FREE daily email newsletter.

Leave a Reply